Xinglu Zhou

Title: The Innovations of Xinglu Zhou

Introduction

Xinglu Zhou is a notable inventor based in Hangzhou, China. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on selective Bruton's tyrosine kinase inhibitors. His research and inventions have the potential to impact drug development and treatment options.

Latest Patents

Xinglu Zhou holds 1 patent for his invention titled "Selective Bruton's tyrosine kinase inhibitor and use thereof." This invention relates to a selective Bruton's tyrosine kinase (BTK) inhibitor compound, a pharmaceutical composition, preparation, and its use in drug formulation. The compound features a specific structure that includes various substituents, enhancing its efficacy in pharmaceutical applications.

Career Highlights

Throughout his career, Xinglu Zhou has worked with prominent companies in the pharmaceutical industry, including Hangzhou Hertz Pharmaceutical Co., Ltd. and Hangzhou Healzen Therapeutics Co., Ltd. His experience in these organizations has allowed him to develop and refine his innovative ideas.

Collaborations

Xinglu Zhou has collaborated with several professionals in his field, including Miao Hu and Xingguo Liu. These partnerships have contributed to the advancement of his research and the successful development of his inventions.

Conclusion

Xinglu Zhou's work exemplifies the spirit of innovation in the pharmaceutical industry. His contributions, particularly in the area of selective Bruton's tyrosine kinase inhibitors, highlight the importance of research and collaboration in developing new therapeutic options.